AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 14, 2026

Myriad Genetics Inc MYGN Stock Forecast

AI-powered price prediction and analysis for Myriad Genetics Inc · Total · absolute moveSwitch to Alpha

Follow
AI 90-Day Forecast ▲ Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence n/a Spearman Correlation

See MYGN's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

MYGN
Fundamentals

Key Statistics

Market Cap$390M
P/B Ratio1.28x
EPS$-0.84
ROE-37.1%
Net Margin-14.0%
Revenue$806M
Current Ratio2.21x
D/E Ratio1.10x
Company

About Myriad Genetics Inc

Myriad Genetics Inc (MYGN) operates within the Life Sciences sector, specifically in the In Vitro & In Vivo Diagnostic Substances industry.

Life Sciences In Vitro & In Vivo Diagnostic Substances Nasdaq Small Cap
News

Latest News

  • Loading...

Where MYGN sits on the market map

Life Sciences · In Vitro & In Vivo Diagnostic Substances
Explore the map →
Industry Peers

In Vitro & In Vivo Diagnostic Substances Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
MYGN Myriad Genetics Inc ▲ $390M –
IDXX Idexx Laboratories Inc /De ▼ $40.99B 36.0x
LNTH Lantheus Holdings, Inc. ▼ $6.53B 23.7x
NEOG Neogen Corp ▲ $2.56B –
CLDX Celldex Therapeutics, Inc. ▲ $2.22B –
NTLA Intellia Therapeutics, Inc. ▲ $1.67B –
QDEL Quidelortho Corp ▲ $967M –
ACHV Achieve Life Sciences, Inc. ▲ $720M –
TKNO Alpha Teknova, Inc. ▲ $441M –
ICCC Immucell Corp /De/ ▲ $98M –
IMDX Insight Molecular Diagnostics Inc. ▲ $98M –
AWHL Aspira Women's Health Inc. ▲ $12M –
BMRA Biomerica Inc ▲ $8M –
CDIO Cardio Diagnostics Holdings, Inc. ▲ $5M –
VNRX Volitionrx Ltd ▶ $3M –
QCLS Q/C Technologies, Inc. ▼ N/A –
TRIB Trinity Biotech Plc ▶ N/A –
FAQ

FAQ

Is Myriad Genetics Inc a good stock to buy?

Our AI analyzes Myriad Genetics Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Myriad Genetics Inc predictions?

A per-ticker accuracy statistic for MYGN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Myriad Genetics Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Myriad Genetics Inc? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.